Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
72 studies found for:    Open Studies | "Parathyroid Diseases"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Parathyroid Diseases" (72 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Anti-3-[18F]FACBC Imaging of Parathyroid Adenomas
Condition: Parathyroid Disease
Intervention: Drug: FACBC
2 Recruiting EIS in Thyroid and Parathyroid Surgery
Conditions: Thyroidectomy;   Parathyroid Diseases
Intervention: Device: Electrical Impedance Spectroscopy
3 Unknown  Preliminary Study for Identification of Calcium-Binding Proteins in the Serum in Various Metabolic Bone Disorders
Conditions: Osteoporosis;   Osteitis Deformans;   Parathyroid Diseases
4 Recruiting Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Conditions: Neuroendocrine Neoplasms;   Thyroid Neoplasms;   Parathyroid Neoplasms;   Adrenal Neoplasm;   Neuroblastoma
5 Recruiting Extended Use of Recombinant Human Parathyroid Hormone (rhPTH(1-84)) in Hypoparathyroidism
Conditions: Chronic Hypoparathyroidism;   Hypoparathyroidism
Intervention: Drug: rhPTH(1-84)
6 Recruiting Safety and Efficacy Study of NFC-1 in Subjects Aged 12-17 Years With 22q11.2DS & Associated Neuropsychiatric Conditions
Condition: 22q11.2 Deletion Syndrome
Interventions: Drug: NFC-1;   Drug: Placebo
7 Not yet recruiting Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis
Condition: Secondary Hyperparathyroidism-Chronic Kidney Disease
Interventions: Drug: Doxercalciferol (GZ427397);   Drug: Calcitriol
8 Recruiting Preliminary Study Concerning the Validity of Parathyroid Exploration on a CZT Camera
Condition: Primary Hyperparathyroidism
Intervention: Device: Tomoscintigraphic parathyroid imaging on a CZT camera
9 Not yet recruiting Localization of Parathyroid Adenoma by Fluorocholine PET/MRI (Positron Emission Tomography -MRI)
Condition: Primary Hyperthyroidism
Interventions: Device: PET-MR;   Device: PET-CT
10 Recruiting Survey on Epidemiology of Hypoparathyroidism in France
Condition: Hypoparathyroidism
Intervention: Other: No intervention
11 Not yet recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Conditions: Acinar Cell Carcinoma;   Adrenal Cortex Carcinoma;   Adrenal Gland Pheochromocytoma;   Anal Canal Neuroendocrine Carcinoma;   Anal Canal Undifferentiated Carcinoma;   Appendix Mucinous Adenocarcinoma;   Bladder Adenocarcinoma;   Bronchioloalveolar Carcinoma;   Cervical Adenocarcinoma;   Cervical Squamous Cell Carcinoma, Not Otherwise Specified;   Cholangiocarcinoma;   Chordoma;   Colorectal Squamous Cell Carcinoma;   Endometrial Adenocarcinoma;   Endometrioid Adenocarcinoma;   Esophageal Neuroendocrine Carcinoma;   Esophageal Undifferentiated Carcinoma;   Extrahepatic Bile Duct Carcinoma;   Fallopian Tube Adenocarcinoma;   Fibromyxoid Tumor;   Gastric Neuroendocrine Carcinoma;   Gastric Squamous Cell Carcinoma;   Giant Cell Carcinoma;   Intestinal Neuroendocrine Carcinoma;   Intrahepatic Cholangiocarcinoma;   Lung Carcinoid Tumor;   Lung Sarcomatoid Carcinoma;   Major Salivary Gland Carcinoma;   Malignant Odontogenic Neoplasm;   Malignant Peripheral Nerve Sheath Tumor;   Malignant Skin Neoplasm;   Malignant Testicular Sex Cord-Stromal Tumor;   Metastatic Malignant Neoplasm of Unknown Primary Origin;   Mixed Mesodermal (Mullerian) Tumor;   Mucinous Adenocarcinoma;   Mucinous Cystadenocarcinoma;   Nasal Cavity Adenocarcinoma;   Nasal Cavity Carcinoma;   Nasopharyngeal Carcinoma;   Nasopharyngeal Papillary Adenocarcinoma;   Nasopharyngeal Undifferentiated Carcinoma;   Oral Cavity Carcinoma;   Oropharyngeal Undifferentiated Carcinoma;   Ovarian Adenocarcinoma;   Ovarian Germ Cell Tumor;   Ovarian Mucinous Adenocarcinoma;   Ovarian Squamous Cell Carcinoma;   Pancreatic Acinar Cell Carcinoma;   Pancreatic Neuroendocrine Carcinoma;   Paraganglioma;   Paranasal Sinus Adenocarcinoma;   Paranasal Sinus Carcinoma;   Parathyroid Gland Carcinoma;   Pituitary Gland Carcinoma;   Placental Choriocarcinoma;   Placental-Site Gestational Trophoblastic Tumor;   Primary Peritoneal High Grade Serous Adenocarcinoma;   Pseudomyxoma Peritonei;   Scrotal Squamous Cell Carcinoma;   Seminal Vesicle Adenocarcinoma;   Seminoma;   Serous Cystadenocarcinoma;   Small Intestinal Adenocarcinoma;   Small Intestinal Squamous Cell Carcinoma;   Spindle Cell Neoplasm;   Squamous Cell Carcinoma of the Penis;   Teratoma With Malignant Transformation;   Testicular Non-Seminomatous Germ Cell Tumor;   Thyroid Gland Carcinoma;   Tracheal Carcinoma;   Transitional Cell Carcinoma;   Undifferentiated Gastric Carcinoma;   Ureter Adenocarcinoma;   Ureter Squamous Cell Carcinoma;   Urethral Adenocarcinoma;   Urethral Squamous Cell Carcinoma;   Vaginal Adenocarcinoma;   Vaginal Squamous Cell Carcinoma, Not Otherwise Specified;   Vulvar Adenocarcinoma;   Vulvar Squamous Cell Carcinoma
Interventions: Procedure: Biospecimen Collection;   Biological: Ipilimumab;   Biological: Nivolumab
12 Not yet recruiting A Single-dose Study in Paediatric Subjects Aged 2 to Less Than 18 Years With (sHPT) Receiving Haemodialysis
Condition: Chronic Kidney Disease, Secondary Hyperparathyroidism
Intervention: Drug: Study Drug
13 Not yet recruiting Investigation of the Optimal Calcium Supplement Following Roux-en-Y Gastric Bypass
Conditions: Roux-en-Y Gastric Bypass;   Hyperparathyroidism, Secondary
Interventions: Dietary Supplement: Calcium Carbonate;   Dietary Supplement: Calcium Citrate;   Dietary Supplement: Placebo;   Procedure: Roux-en-Y gastric bypass
14 Recruiting Expanded Noninvasive Genomic Medical Assessment: The Enigma Study
Conditions: Down Syndrome;   Edwards Syndrome;   Patau Syndrome;   Klinefelter Syndrome;   Turner Syndrome;   DiGeorge Syndrome;   Chromosome Deletion;   Aneuploidy
Intervention: Other: Blood sampling for Laboratory Developed Test (LDT) analysis
15 Recruiting Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Subjects With Hypoparathyroidism
Condition: Hypoparathyroidism
Interventions: Drug: 25mcg rhPTH(1-84);   Drug: 50mcg rhPTH(1-84);   Drug: 100mcg rhPTH(1-84)
16 Recruiting Insulin Resistance in Primary Hyperparathyroidism
Conditions: Hyperparathyroidism;   Diabetes;   Hypercalcemia
Intervention: Procedure: parathyroidectomy
17 Recruiting Steroids in the Postoperative Transient Hypoparathyroidism Total Thyroidectomy
Condition: Transient Hypoparathyroidism
Interventions: Drug: phosphate and betamethasone acetate, 2 mL.;   Drug: saline 0.9% NaCl
18 Recruiting Optimal HCTZ Cessation for Diagnosis of Hyperparathyroidism
Condition: Hyperparathyroidism
Intervention: Procedure: NO hydrochlorothiazide (HCTZ)
19 Recruiting Systematic Study of Parameters of Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD)
Condition: Renal Osteodystrophy
20 Recruiting Characterization of Patients With Non-surgical Hypoparathyroidism and Pseudohypoparathyroidism
Conditions: Idiopathic Hypoparathyroidism;   Autosomal Dominant Hypocalcaemia;   Pseudohypoparathyroidism

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years